IgD multiple myeloma preceding the development of extensive extramedullary disease without medullary involvement

Acta Haematologica

Volumn 104, Issue 1, 2000, Pages 42-45

  Iwasaki, Tsuyoshi ^a   Hamano, Teruaki ^a   Ogata, Atsushi ^a   Hashimoto, Naoaki ^a   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Extramedullary disease; IgD; Multiple myeloma; Plasmacytoma

Indexed keywords

ALPHA INTERFERON; BENCE JONES PROTEIN; IMMUNOGLOBULIN D; LACTATE DEHYDROGENASE; MELPHALAN; RANIMUSTINE; VINCRISTINE;

ANEMIA; ARTICLE; BONE MARROW BIOPSY; CHEMOTHERAPY; CLINICAL FEATURE; DISEASE COURSE; EXTRAMEDULLARY HEMATOPOIESIS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALIGNANT TRANSFORMATION; MULTIPLE MYELOMA; PLASMA CELL; PLASMACYTOMA; PLASMACYTOSIS; PRIORITY JOURNAL;

EID: 0033662712     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000041069     Document Type: Article

References (10)

1. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis
2. Extramedullary lesions in multiple myeloma: Review of literature and pathologic studies
3. IgG multiple myeloma: Review of 133 cases
4. Cutaneous plasmacytoma in myeloma: Relationship to tumor cell burden
5. Secondary cutaneous plasmacytoma
6. Discordant LFA-1/ICAM-1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytoma
7. Plasma cell myeloma: New biological insights and advances in therapy
8. Cellular and molecular genetic features of myeloma and related disorders
9. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma
10. Extensive extramedullary disease in myeloma: An uncommon variant with features of poor prognosis and dedifferentiation